United States · FDA National Drug Code directory
PALIPERIDONE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43975-352_57a9842e-b847-e3c7-e063-6294a90af4fc
- Product NDC
- 43975-352
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- PALIPERIDONE
- Labeler
- ANI Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20191127
- Source listing expiry
- 20271231
Source-listed ingredients
- PALIPERIDONE — 9 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43975-352-03) · 43975-352-03
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →